Quiñones Jason Luis, Demple Bruce
Stony Brook University School of Medicine, Department of Pharmacological Sciences, Stony Brook, NY, 11794, USA.
Stony Brook University School of Medicine, Department of Pharmacological Sciences, Stony Brook, NY, 11794, USA.
DNA Repair (Amst). 2016 Aug;44:103-109. doi: 10.1016/j.dnarep.2016.05.014. Epub 2016 May 20.
Free radicals generate an array of DNA lesions affecting all parts of the molecule. The damage to deoxyribose receives less attention than base damage, even though the former accounts for ∼20% of the total. Oxidative deoxyribose fragments (e.g., 3'-phosphoglycolate esters) are removed by the Ape1 AP endonuclease and other enzymes in mammalian cells to enable DNA repair synthesis. Oxidized abasic sites are initially incised by Ape1, thus recruiting these lesions into base excision repair (BER) pathways. Lesions such as 2-deoxypentos-4-ulose can be removed by conventional (single-nucleotide) BER, which proceeds through a covalent Schiff base intermediate with DNA polymerase β (Polβ) that is resolved by hydrolysis. In contrast, the lesion 2-deoxyribonolactone (dL) must be processed by multinucleotide ("long-patch") BER: attempted repair via the single-nucleotide pathway leads to a dead-end, covalent complex with Polβ cross- linked to the DNA by an amide bond. We recently detected these stable DNA-protein crosslinks (DPC) between Polβ and dL in intact cells. The features of the DPC formation in vivo are exactly in keeping with the mechanistic properties seen in vitro: Polβ-DPC are formed by oxidative agents in line with their ability to form the dL lesion; they are not formed by non-oxidative agents; DPC formation absolutely requires the active-site lysine-72 that attacks the 5'-deoxyribose; and DPC formation depends on Ape1 to incise the dL lesion first. The Polβ-DPC are rapidly processed in vivo, the signal disappearing with a half-life of 15-30min in both mouse and human cells. This removal is blocked by inhibiting the proteasome, which leads to the accumulation of ubiquitin associated with the Polβ-DPC. While other proteins (e.g., topoisomerases) also form DPC under these conditions, 60-70% of the trapped ubiquitin depends on Polβ. The mechanism of ubiquitin targeting to Polβ-DPC, the subsequent processing of the expected 5'-peptidyl-dL, and the biological consequences of unrepaired DPC are important to assess. Many other lyase enzymes that attack dL can also be trapped in DPC, so the processing mechanisms may apply quite broadly.
自由基会产生一系列影响分子各个部分的DNA损伤。与碱基损伤相比,脱氧核糖受到的关注较少,尽管前者占总数的约20%。氧化的脱氧核糖片段(如3'-磷酸乙醇酸酯)在哺乳动物细胞中由Ape1 AP核酸内切酶和其他酶去除,以进行DNA修复合成。氧化的无碱基位点最初由Ape1切割,从而将这些损伤纳入碱基切除修复(BER)途径。诸如2-脱氧戊糖-4-酮等损伤可通过传统的(单核苷酸)BER去除,该过程通过与DNA聚合酶β(Polβ)形成的共价席夫碱中间体进行,该中间体通过水解得到解决。相比之下,损伤2-脱氧核糖内酯(dL)必须通过多核苷酸(“长补丁”)BER进行处理:通过单核苷酸途径进行的修复尝试会导致与Polβ形成死端的共价复合物,该复合物通过酰胺键与DNA交联。我们最近在完整细胞中检测到了Polβ与dL之间的这些稳定的DNA-蛋白质交联(DPC)。体内DPC形成的特征与体外观察到的机制特性完全一致:Polβ-DPC由氧化剂形成,与其形成dL损伤的能力一致;它们不是由非氧化剂形成的;DPC的形成绝对需要活性位点赖氨酸-72攻击5'-脱氧核糖;并且DPC的形成取决于Ape1首先切割dL损伤。Polβ-DPC在体内迅速被处理,在小鼠和人类细胞中信号以15-30分钟的半衰期消失。通过抑制蛋白酶体可阻止这种去除,这会导致与Polβ-DPC相关的泛素积累。虽然其他蛋白质(如拓扑异构酶)在这些条件下也会形成DPC,但60-70%被困的泛素取决于Polβ。评估泛素靶向Polβ-DPC的机制、预期的5'-肽基-dL的后续处理以及未修复的DPC的生物学后果很重要。许多其他攻击dL的裂解酶也可能被困在DPC中,因此处理机制可能应用广泛。